Google Übersetzer
Perspective Therapeutics, Inc.
About
3.98USD+0.11 +2.84%
Closed • Updated at 10:23 GMT+00:00Market Cap$453.90M
Volume1.72M
Beta0.61
RSI50.06
Gross Margin-489.81%
Perspective Therapeutics, Inc. — investor relations, events, news, and company updates on 6ix.
Latest News
May 18 2026
Perspective Therapeutics Announces First Patients Dosed in New Cohorts of Two Ongoing Phase 1/2a Studies
Apr 24 2026
Perspective Therapeutics to Provide Several Upcoming Corporate Updates
Apr 20 2026
Perspective Therapeutics Presents Updated Interim Data of [212Pb]VMT-α-NET in Its Ongoing Phase 1/2a Clinical Trial at the 2026 AACR Annual Meeting
Apr 2 2026
Perspective Therapeutics to Participate in Upcoming Investor Conferences
Mar 17 2026
Perspective Therapeutics Announces Acceptance of VMT-α-NET Data for Presentation at the AACR Annual Meeting 2026
Recent Videos
CATX Clinical Trial Data: My Take on the 8-K
Apr 20, 2026
Radiotherapeutics For Neuroendocrine Tumors With Perspective Therapeutics' Thijs Spoor
Apr 06, 2026
March 20, 2026
Mar 20, 2026
Cómo comprar acciones de Perspective Therapeutics Inc (CATX)
Mar 13, 2026
Community Chat
Ask AI
Try asking